Australia markets close in 3 hours 32 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
156.18+6.70 (+4.48%)
At close: 4:00PM EDT

154.00 -2.18 (-1.40%)
After hours: 7:59PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 537.72B
Enterprise value 335B
Trailing P/E N/A
Forward P/E 18.83
PEG ratio (5-yr expected) 1-0.10
Price/sales (ttm)78.21
Price/book (mrq)N/A
Enterprise value/revenue 372.56
Enterprise value/EBITDA 7-119.30

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3179.40%
S&P500 52-week change 348.72%
52-week high 3157.30
52-week low 343.00
50-day moving average 3110.05
200-day moving average 3104.71

Share statistics

Avg vol (3-month) 31.9M
Avg vol (10-day) 33.49M
Shares outstanding 5241.52M
Implied shares outstanding 6N/A
Float 78.56M
% held by insiders 11.18%
% held by institutions 110.57%
Shares short (30 Mar 2021) 44.76M
Short ratio (30 Mar 2021) 43.35
Short % of float (30 Mar 2021) 4N/A
Short % of shares outstanding (30 Mar 2021) 41.97%
Shares short (prior month 25 Feb 2021) 43.63M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin 3.15%
Operating margin (ttm)-67.55%

Management effectiveness

Return on assets (ttm)-13.07%
Return on equity (ttm)1.63%

Income statement

Revenue (ttm)482.32M
Revenue per share (ttm)2.05
Quarterly revenue growth (yoy)1,134.30%
Gross profit (ttm)-222.04M
EBITDA -293.35M
Net income avi to common (ttm)15.2M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.35B
Total cash per share (mrq)5.58
Total debt (mrq)240.19M
Total debt/equity (mrq)17.51
Current ratio (mrq)2.75
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-13.47M
Levered free cash flow (ttm)-35.53M